Parasitic Diseases Therapeutics

Parasitic Diseases Therapeutics


Global Parasitic Diseases Therapeutics Market to Reach US$2.2 Billion by 2030

The global market for Parasitic Diseases Therapeutics estimated at US$1.7 Billion in the year 2023, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Anthelmintics Drugs, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Antiprotozoals Drugs segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$473.1 Million While China is Forecast to Grow at 6.4% CAGR

The Parasitic Diseases Therapeutics market in the U.S. is estimated at US$473.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$449.5 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Parasitic Diseases Therapeutics Market - Key Trends and Drivers Summarized

Parasitic diseases, caused by various organisms such as protozoa, helminths, and ectoparasites, continue to pose significant public health challenges worldwide, particularly in tropical and subtropical regions. These diseases, including malaria, leishmaniasis, schistosomiasis, and lymphatic filariasis, often result in severe morbidity and mortality, particularly among children and immunocompromised individuals. Therapeutics for parasitic diseases involve a range of treatments designed to eliminate the parasites from the host body, alleviate symptoms, and prevent transmission. Traditional treatments have included antiparasitic drugs such as chloroquine for malaria and albendazole for helminth infections, which have been the mainstay of treatment for decades. However, the emergence of drug-resistant strains of parasites has necessitated the development of new and more effective therapeutics to combat these diseases.

Recent advancements in the field of parasitic disease therapeutics have been driven by innovative research and development efforts focusing on novel drug discovery, vaccine development, and combination therapies. Researchers are employing high-throughput screening techniques to identify new drug candidates, leveraging advances in genomics and proteomics to understand parasite biology better and discover new drug targets. The development of vaccines against parasitic diseases, such as the RTS,S/AS01 malaria vaccine, represents a significant breakthrough in preventing infection and reducing disease burden. Additionally, combination therapies, which use multiple drugs with different mechanisms of action, are being increasingly utilized to enhance treatment efficacy and delay the onset of drug resistance. This multifaceted approach is crucial in managing parasitic diseases, given the complex life cycles of parasites and their ability to adapt and survive under various conditions.

The growth in the parasitic diseases therapeutics market is driven by several factors, including the increasing prevalence of parasitic infections due to global travel, climate change, and inadequate sanitation in developing regions. Technological advancements in diagnostic tools have improved the early detection and accurate diagnosis of parasitic diseases, facilitating timely and effective treatment. Consumer behavior, particularly in regions with high disease prevalence, shows a growing demand for accessible and affordable treatments. Additionally, global health initiatives and funding from organizations such as the World Health Organization (WHO) and the Bill & Melinda Gates Foundation have provided substantial support for research and development in this field. Regulatory incentives and fast-track approvals for new antiparasitic drugs and vaccines also contribute to market growth. As pharmaceutical companies continue to invest in innovative treatments and expand their reach into emerging markets, the parasitic diseases therapeutics market is expected to grow, offering improved health outcomes and enhanced quality of life for affected populations.

Select Competitors (Total 42 Featured) -
  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Cipla Ltd
  • GSK Plc
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer, Inc.
  • Reese Pharmaceutical Company
  • Sanaria Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals USA, Inc.
  • Victor Medical Company
  • Zydus Pharmaceuticals (USA) Inc.
  • ;
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Parasitic Diseases Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Global Burden of Parasitic Diseases Drives Urgent Need for Effective Therapeutics
Breakthroughs in Molecular Biology and Parasitology Propel Drug Development
Expansion of Global Health Initiatives to Combat Malaria, Chagas Disease, and Others to Benefit Growth
Impact of Climate Change on Parasitic Disease Spread and Epidemiology
Governmental Funding and Policy Support for Neglected Tropical Diseases, Remain Crucial for New Drug Development
Development of Vaccines as a Preventative Strategy Against Parasitic Infections
Rising Travel and Migration Patterns Influence Disease Transmission Dynamics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Parasitic Diseases Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Parasitic Diseases Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Parasitic Diseases Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Anthelmintics Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Anthelmintics Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Anthelmintics Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Antiprotozoals Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Antiprotozoals Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Antiprotozoals Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Distribution Channel Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Distribution Channel Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Other Distribution Channel Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
JAPAN
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
CHINA
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
EUROPE
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Parasitic Diseases Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Parasitic Diseases Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
FRANCE
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
GERMANY
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
UNITED KINGDOM
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Parasitic Diseases Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Parasitic Diseases Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
AUSTRALIA
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
INDIA
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 113: India Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
LATIN AMERICA
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Parasitic Diseases Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Parasitic Diseases Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
MIDDLE EAST
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Parasitic Diseases Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Parasitic Diseases Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
AFRICA
Parasitic Diseases Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Parasitic Diseases Therapeutics by Drug Type - Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Parasitic Diseases Therapeutics by Drug Type - Percentage Breakdown of Value Sales for Anthelmintics Drugs, Antiprotozoals Drugs and Other Drug Types for the Years 2014, 2024 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Parasitic Diseases Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for Parasitic Diseases Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Other Distribution Channel Pharmacies for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings